General Information of the Compound
| Compound ID |
CP0869699
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-2-Ethyl-N-(4-(((2S,5R)-5-((R)-hydroxy(pyridin-3-yl)-methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4Hcyclopenta[d]thiazole-4-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H30N4O2S
|
||||||||||||||||||
| Molecular Weight |
462.619
|
||||||||||||||||||
| Canonical SMILES |
CCc1nc2c(s1)CC[C@H]2C(=O)Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H30N4O2S/c1-2-23-30-24-20(10-12-22(24)33-23)26(32)29-18-7-5-16(6-8-18)14-19-9-11-21(28-19)25(31)17-4-3-13-27-15-17/h3-8,13,15,19-21,25,28,31H,2,9-12,14H2,1H3,(H,29,32)/t19-,20+,21+,25+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DFVXRWSFKFUTBL-UWHHFBIGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor